Product information

Hyrimoz 80 mg
0.8 ml
adalimumab
4733259
0 / 10
Locked

Product properties

331731-18-1
L04AB04
Sandoz
Solution for injection in pre-filled pen, Dummy Pharmaceutical Form
€403.12
EU/1/18/1286/010
07613421155315
M42
Public
661354-01

Pharmacist Assessment

Commercialization officially ended — no stock

SAM has flagged this product as commercially stopped (reason: Insufficient demand) and no stock is available from wholesalers. Switching to an alternative is necessary.

Recommended alternative

Different strength — dose adjustment required. Consult the physician.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Active
- present

Insufficient demand

Alternative available
Available
Until 30/03/2026

Composition

4 ingredients

Substance Type Strength CAS
Active ingredient
100 mg/mL
331731-18-1
Excipient
Excipient
Excipient

Additional information

View on BCPI

Availability statistics

Commercialization stopped
215 days
3
0
31/03/2026